Skip to main content
Caplight Logo









OptoCeutics

OptoCeutics

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://optoceutics.com/

Last Round

Grant

Dec 20, 2020

Total Funding Raised

$579,000

Company Overview

OptoCeutics is a health technology company that provides a non-invasive, light-based therapeutic device called EVY LIGHT® designed to improve brain health and cognitive function.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, D2C Brands, Clinical Trials

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

40Hz light stimulationgamma wave entrainmentnon-invasive therapylight therapy deviceneuromodulationcognitive declineAlzheimer's therapyneurotechbrain stimulationat-home therapydementia caremild cognitive impairmentMCIcognitive enhancementwellness devicedirect-to-consumerbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OptoCeutics Comparables

Compare OptoCeutics with similar companies based on industry and business-model similarity.

OptoCeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Healyan
86%
Cognito Therapeutics
84%
Vielight Inc.
83%

OptoCeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 20, 2020

Key People

Founding team and executive leadership

Marcus Carstensen

Co-Founder & Chief Scientific Officer

Founding Team

Ngoc Mai Nguyen

CEO, Co-founder

Founding Team

Jeff Waggoner

Chief Financial Officer

Executive Team

OptoCeutics Investors

Notable investors and investment history

OptoCeutics investors
InvestorRounds
Innovation Fund DenmarkGrant
European Innovation Council FundGrant
EIT HealthGrant
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Grew 20% QoQ, from 15 to 18 employees.

  • Nov 13, 2025

    Monthly visitors increased 36% MoM, reaching 79.4K.

OptoCeutics Filings

Explore SEC and related filing metadata, where available.

OptoCeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OptoCeutics's valuation, stock price, and market status.

Is OptoCeutics a public or private company?

OptoCeutics is a private company.

What is the current stock price of OptoCeutics?

OptoCeutics is a private company with no public stock price. No recent secondary market data is available.

How much is OptoCeutics worth (valuation)?

Valuation information for OptoCeutics is not publicly available.

Can I buy OptoCeutics stock?

OptoCeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OptoCeutics's last funding round?

OptoCeutics's most recent funding round was Grant on December 20, 2020.

Who are the main investors in OptoCeutics?

Key investors in OptoCeutics include Innovation Fund Denmark, European Innovation Council, EIT Health, European Union.

Will OptoCeutics IPO soon?

No public IPO plans have been announced for OptoCeutics.

How can I track OptoCeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OptoCeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerkeley, California
Employee Range12
Year Founded2018
Last FundingDec 20, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?